S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Lithium Overdose: Can These 2 Lithium Stocks Recover in 2024?
North Carolina medical marijuana sales begin at Cherokee store
'Civil War’ continues box-office campaign at No. 1
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
Intuitive Surgical Leads the Robotic Surgery Movement
Stock market today: Wall Street eyes corporate earnings after last week's Big Tech selloff
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Lithium Overdose: Can These 2 Lithium Stocks Recover in 2024?
North Carolina medical marijuana sales begin at Cherokee store
'Civil War’ continues box-office campaign at No. 1
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
Intuitive Surgical Leads the Robotic Surgery Movement
Stock market today: Wall Street eyes corporate earnings after last week's Big Tech selloff
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Lithium Overdose: Can These 2 Lithium Stocks Recover in 2024?
North Carolina medical marijuana sales begin at Cherokee store
'Civil War’ continues box-office campaign at No. 1
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
Intuitive Surgical Leads the Robotic Surgery Movement
Stock market today: Wall Street eyes corporate earnings after last week's Big Tech selloff
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Lithium Overdose: Can These 2 Lithium Stocks Recover in 2024?
North Carolina medical marijuana sales begin at Cherokee store
'Civil War’ continues box-office campaign at No. 1
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
Intuitive Surgical Leads the Robotic Surgery Movement
Stock market today: Wall Street eyes corporate earnings after last week's Big Tech selloff
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
LON:STJ

St. James's Place (STJ) Share Price, News & Analysis

GBX 428.60
+5.60 (+1.32%)
(As of 08:33 AM ET)
Today's Range
424.20
435.20
50-Day Range
402
662.60
52-Week Range
393.60
1,245
Volume
23.76 million shs
Average Volume
2.62 million shs
Market Capitalization
£2.35 billion
P/E Ratio
N/A
Dividend Yield
5.60%
Price Target
GBX 710.50

St. James's Place MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.60 Rating Score
Upside/​Downside
65.8% Upside
GBX 710.50 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
-0.39
Upright™ Environmental Score
News Sentiment
-0.06mentions of St. James
Based on 4 Articles This Week
Insider Trading
Acquiring Shares
£197,072 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.45 out of 5 stars

STJ stock logo

About St. James's Place Stock (LON:STJ)

St. James's Place plc is a publicly owned investment manager. The firm launches and manages equity, fixed income, and balanced mutual funds for its clients. It invests in public equity and fixed income market across the globe. The firm was formerly known as St. James's Place Capital plc. St. James's Place plc was founded in 1991 and is based in Cirencester, United Kingdom.

STJ Stock Price History

STJ Stock News Headlines

Healthcare Takes A Big Step Forward With The Help Of AI
The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.
Best parishes to live in Louisiana
St. James's Place (LON:STJ) Reaches New 12-Month Low at $403.60
Healthcare Takes A Big Step Forward With The Help Of AI
The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.
St. James's Place price target lowered by 255 GBp at Barclays
How to get your share of St James’s Place £426m compensation
St. James's Place price target raised by 5 GBp at Barclays
See More Headlines
Receive STJ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for St. James's Place and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/22/2024
Ex-Dividend for 5/24 Dividend
4/25/2024
Dividend Payable
5/24/2024

Industry, Sector and Symbol

Industry
Asset Management
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
2,298
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 710.50
High Stock Price Target
GBX 955
Low Stock Price Target
GBX 500
Potential Upside/Downside
+63.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.60
Research Coverage
5 Analysts

Profitability

Net Income
£-10,100,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£19.01 billion
Cash Flow
GBX 530.97 per share
Book Value
GBX 180 per share

Miscellaneous

Free Float
N/A
Market Cap
£2.38 billion
Optionable
Not Optionable
Beta
1.20
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Mark Thomas FitzPatrick C.A. (Age 56)
    CEO & Executive Director
    Comp: $2.57M
  • Mr. Craig Gordon Gentle (Age 56)
    CFO, Executive Director & Member of Executive Board
    Comp: $797.83k
  • Sir Mark Aubrey Weinberg (Age 93)
    Founder & President
    Comp: $188.44k
  • Lord Nathaniel Charles Rothschild GBE (Age 88)
    OM, Founder
  • Mr. Iain Rayner
    Chief Operating Officer & Member of Executive Board
  • Mr. Ian MacKenzie
    Chief Operations & Technology Officer and Member of Executive Board
  • Ms. Elizabeth J. Kelly
    Chief Corporate Affairs Officer & Member of Executive Board
  • Mr. Peter Edwards
    Partnership Director & Member of Executive Board
  • Mr. Mark Sutton
    Chief Risk Officer & Member of Executive Board
  • Mr. Tom Beal
    Director of Investments & Member of Executive Board

STJ Stock Analysis - Frequently Asked Questions

Should I buy or sell St. James's Place stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for St. James's Place in the last twelve months. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" STJ shares.
View STJ analyst ratings
or view top-rated stocks.

What is St. James' Place's stock price target for 2024?

5 Wall Street research analysts have issued 12 month price objectives for St. James' Place's stock. Their STJ share price targets range from GBX 500 to GBX 955. On average, they predict the company's share price to reach GBX 710.50 in the next year. This suggests a possible upside of 65.8% from the stock's current price.
View analysts price targets for STJ
or view top-rated stocks among Wall Street analysts.

How have STJ shares performed in 2024?

St. James' Place's stock was trading at GBX 683.60 at the start of the year. Since then, STJ stock has decreased by 37.3% and is now trading at GBX 428.60.
View the best growth stocks for 2024 here
.

How often does St. James's Place pay dividends? What is the dividend yield for St. James's Place?

St. James's Place declared a dividend on Wednesday, February 28th. Stockholders of record on Thursday, April 25th will be given a dividend of GBX 8 per share on Friday, May 24th. This represents a dividend yield of 1.29%. The ex-dividend date of this dividend is Thursday, April 25th. The official announcement can be seen at this link.
Read our dividend analysis for STJ
.

Is St. James's Place a good dividend stock?

St. James's Place (LON:STJ) pays an annual dividend of GBX 24 per share and currently has a dividend yield of 5.73%. STJ has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for STJ.

What other stocks do shareholders of St. James's Place own?

Based on aggregate information from My MarketBeat watchlists, some companies that other St. James's Place investors own include International Personal Finance (IPF), Aviva (AV), Glencore (GLEN), HSBC (HSBA), Standard Chartered (STAN), Barclays (BARC), Diageo (DGE), Unilever (ULVR), Ashtead Group (AHT) and Cobham (COB).

How do I buy shares of St. James's Place?

Shares of STJ stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:STJ) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners